Prevalence of diabetes mellitus by Heidemann, Christin et al.
Robert Koch Institute | Federal Health Reporting
Introduction
Diabetes mellitus is a frequently occurring, chronic 
metabolic disease in which the regulation of the blood 
glucose level is impaired. Due to limited insulin action 
(insulin resistance) or insulin production glucose can 
no longer be absorbed from the blood into the cells of 
the body. The consequence is chronically increased 
blood glucose concentrations which - if left untreated - 
can result in damage to blood vessels and nerves. This 
increases the risk of comorbidities and complications 
such as myocardial infarction, stroke, renal dysfunction, 
retinal damage and diabetic foot syndrome (American 
Diabetes Association 2012; Chen, Magliano, Zimmet 
2012). Diabetes mellitus leads to limitations in quality 
of life and in life expectancy (Schunk et al. 2012; Paprott 
et al. 2015). The disease causes high direct and indirect 
costs for the healthcare system (Koster, Schubert, Hup-
pertz 2012).
The most important forms of diabetes mellitus are 
type 1, type 2 and gestational diabetes. Type 1 diabetes 
is an autoimmune disorder primarily occurring during 
childhood and adolescence. In contrast, older adults are 
predominantly affected by the most common form of 
the disease - type 2 diabetes. Risk factors of type 2 dia-
betes - in addition to a genetic predisposition - are in 
particular, an unhealthy diet, a lack of physical exercise 
and the resultant overweight. Gestational diabetes main-
ly only exists during the pregnancy period, however, it 
increases the risk of developing type 2 diabetes later in 
life (Feig et al. 2008).
Indicator
In the ‘German Health Interview and Examination 
Survey for Adults’ (DEGS1), the lifetime prevalence of 
known (physician-diagnosed) diabetes mellitus was esta-
blished as follows: On the one hand in a standardised 
computer-assisted medical interview via the question, 
“Has a doctor ever diagnosed you with diabetes?” and on 
the other hand via documentation of taking anti-diabetic 
drugs in the past 7 days prior to visiting the study centre.
The tables show the lifetime prevalence for diabetes 
mellitus among 18 to 79-year-old adults taking all disease 
forms into account. The results are stratified for gender, 
age and social status.
Key statements
 ▶ 7.2% of adults have ever been diagnosed with 
diabetes (7.4% of women 7.0% of men). 
 ▶ Prevalence increases significantly with 
advancing age.
 ▶ Diabetes mellitus is diagnosed significantly 
more often in people of low social status than 
in those of medium or high social status.
Conclusion
In DEGS1, the lifetime prevalence of known diabetes 
mellitus is 7.2% (7.4% of women; 7.0% of men). This 
corresponds to approximately 4.6 million affected per-
sons in the 18 to 79-year-old population in Germany 
(Heidemann et al. 2013). Prevalence increases with age. 
Although it is still lower than 5% in the under 50-year-old 
age group it increases in the 60 to 69-year-old age group 
to 13.8% and to just under 22% among 70 to 79-year-
olds.
Compared to DEGS1, a slightly higher lifetime pre-
valence was observed in the 2012 Robert Koch Institute 
(RKI) ‘German Health Update’ (GEDA) telephone survey 
(RKI 2012). Here around 8.9% of those surveyed (9.0% 
of the women, 8.7% of the men) stated that they had ever 
been diagnosed with diabetes mellitus. The difference 
can presumably be attributed to the different sampling 
methods (sample of local population registries vs. samp-
le of private households available through landline tele-
phone) and survey methods (personal medical interview 
vs. telephone interview) as well as to the differences in 
the age structures of the two surveys. Whilst in DEGS1 
the data of persons aged between 18 and 79 years was 
analysed, the evaluation of the GEDA study also inclu-
des people aged 80 years and above.
Statements regarding the temporal development in 
the prevalence of diabetes in Germany can be made 
by comparing DEGS1 with its predecessor study the 
‘German National Health Interview and Examination 
Survey’ (GNHIES98). Given simultaneous considera-
tion of self-reported diagnosis and of laboratory data, 
the lifetime prevalence of diagnosed diabetes in the 
GNHIES98 study was 5.0% (5.6% after standardisa-
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Note: A detailed description of the study as well as 
explanations on the method are available on the 
DEGS study website, www.degs-studie.de, and in 
Scheidt-Nave et al. (2012). 
Further results regarding diabetes mellitus in adults 
can be found at Heidemann et al. (2013), Heide-
mann et al. (2015) and Du et al. (2015).
tion of the GNHIES98 data to the altered age structure 
at the time of the DEGS1 study period) (Heidemann et 
al. 2015). The prevalence of known diabetes has thus 
increased since 1998. Approximately one third of this 
increase is to be attributed to the ageing of the popu-
lation (Heidemann et al. 2013). Other reasons may be 
earlier detection and partially improved care of adults 
with diabetes mellitus after introduction of the Disease 
Management Programme in the period between the two 
health surveys (Heidemann et al. 2015; Du et al. 2015; 
Fuchs et al. 2014). In addition, changes in the diagnos-
tic criteria for diabetes mellitus presumably also play a 
role (WHO 1999; Kerner, Brückel 2010).
In addition to known diabetes mellitus, recording 
undiagnosed (untreated) diabetes is also important in 
order not to underestimate the total prevalence of the 
disease in the population-based studies (Heidemann et 
al. 2013). Undiagnosed diabetes can be determined using 
blood samples in which glycated haemoglobin (HbA1c) 
or serum glucose is measured. Evaluations of the DEGS1 
study show that the prevalence of undiagnosed diabe-
tes in Germany in recent years has fallen from 3.4% (or 
3.8% when aged standardised) to 2.0% (Heidemann et 
al. 2015). This could be indicative of the fact that early 
detection of the disease has improved.
Furthermore, the DEGS1 data show that diabetes mel-
litus is diagnosed significantly more often in people of 
low social status than in those of higher social status. 
This applies to undiagnosed as well as diagnosed diabe-
tes, although according to current results social inequal-
ity has not increased further (Heidemann et al. 2015).
In summary, diabetes mellitus is a disease which 
occurs frequently in the German population and which 
is associated with enormous individual and socio-eco-
nomic stressors. Basic prevention and care measures are 
avoiding the development of type 2 diabetes risk factors, 
early detection of the disease and avoiding the occur-
rence of diabetic complications and secondary diseases.
In order to create continuous national diabetes report-
ing and a comprehensive, data-driven decision-making 
basis for health policy, a ‘National Diabetes Surveillance’ 
system is being established at the RKI. RKI primary 
data as well as secondary data will be integrated in this 
surveillance system. For more information about this 
project see www.rki.de.
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Table 1 
Lifetime prevalence of diagnosed diabetes mellitus in 18 to 79-year-old 
women according to age and social status
Table 2 
Lifetime prevalence of diagnosed diabetes mellitus in 18 to 79-year-old 
men according to age and social status
Lifetime prevalence of 
diagnosed diabetes mellitus
% (95%-CI)
Women 7.4 (6.5 – 8.5)
Age
18 – 39 Years 3.7 (2.5 – 5.5)
40 – 49 Years 4.5 (3.0 – 6.8)
50 – 59 Years 4.0 (2.6 – 6.0)
60 – 69 Years 10.7 (8.2 – 13.8)
70 – 79 Years 21.8 (17.6–26.7)
Social status
Low 11.6 (8.6 – 15.5)
Middle 7.4 (6.3 – 8.7)
High 3.0 (2.0 – 4.5)
Total (women and men) 7.2 (6.5 – 8.0)
Lifetime prevalence of 
diagnosed diabetes mellitus
% (95%-CI)
Men 7.0 (6.0 – 8.1)
Age
18 – 39 Years 0.9 (0.3 – 2.3)
40 – 49 Years 2.0 (1.1 – 3.7)
50 – 59 Years 7.3 (5.3 – 10.1)
60 – 69 Years 17.0 (13.1 – 21.7)
70 – 79 Years 22.0 (17.6–27.2)
Social status
Low 10.1 (7.5 – 13.5)
Middle 6.1 (5.1 – 7.4)
High 6.2 (4.6 – 8.3)
Total (women and men) 7.2 (6.5 – 8.0)
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